Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma

Background: Proton beam has an excellent depth dose distribution due to its unique physical properties, and thus proton beam therapy (PBT) has been tried and showed promising outcomes in hepatocellular carcinoma (HCC). The purpose of this phase II study is to evaluate the efficacy of hypofractionate...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Oncol
Main Authors: Kim, Tae Hyun, Park, Joong-Won, Kim, Bo Hyun, Oh, Eun Sang, Youn, Sang Hee, Moon, Sung Ho, Kim, Sang Soo, Woo, Sang Myung, Koh, Young-Hwan, Lee, Woo Jin, Kim, Dae Yong
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2020
Assuntos:
Oncology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7198869/
https://ncbi.nlm.nih.gov/pubmed/32411594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00542
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares